• Skip to primary navigation
  • Skip to main content
  • Skip to footer

Target ALS

A New York based ALS research organization that's leading the fight for a cure.

  • DONATE
  • About Us
    • Our Mission
    • Our Model
    • Our Impact
    • Our Founder
    • Our Team
    • Our Partners
  • For Scientists
    • Research Cores
      • Target ALS Data Engine
      • Longitudinal Biofluids Core
      • Human Postmortem Tissue Core
      • Stem Cell Core
      • Reagents Core
      • Animal Models Core
    • Funding Opportunities
    • Funded Projects
    • Annual Meeting
    • Science on Target Blog
  • Understanding ALS
    • About ALS
    • Understanding the Science
      • Glossary
      • FAQ
      • ALS 101
    • Voices of ALS
    • Video Library
  • Take Action
    • Support Geoff Greulich
    • The ALS Global Research Initiative (AGRI)
      • Global Natural History Study
      • Community Based Pop-Up Clinics
    • Ways to Give
    • Email Sign Up
    • Contact Us
    • Donate Now
  • News
    • Announcements
    • In the News
    • Newsletters & Reports

Glossary

Amyotrophic lateral sclerosis, more commonly known as ALS, is a progressive neurodegenerative disease in the central nervous system that impacts the brain and spinal cord, resulting in a loss of muscle control.

It is colloquially referred to as Lou Gehrig’s Disease, after the famous baseball player who battled it in the late 1930s, and does not yet have a cure. To better understand the language of ALS, the ALS Glossary below provides definitions for research terms commonly used by our Innovation Ecosystem and the extended ALS community.

ABCDEFGHIKLMNPRSTUWAll

AAV vector

An adeno-associated virus (AAV) vector is the part of a virus able to enter cells, but lacks any of the cell's damaging properties. AAV vectors can be genetically engineered to deliver a gene by selectively "infecting" the cell. AAV vectors have become one of the most common vehicles for gene delivery.

abnormal proteins

Abnormal proteins do not function as they should and are often produced by genetic mutations. TDP-43 is an example of a protein that becomes abnormal in ALS patients and becomes dysfunctional and clumps.

activities of daily living (ADLs)

The fundamental skills required to independently care for oneself. Basic ADLs include eating, dressing and toileting. Instrumental ADLs include managing transportation, shopping, finances and medications.

ALS (amyotrophic lateral sclerosis)

 A progressive and fatal neurodegenerative disease that affects nerve cells in the brain and the spinal cord.

ALS advocate

 A person who works to increase awareness of and allocation of resources to ALS research, treatment, and/or other aspects of care.

Alzheimer's disease

The most common form of dementia, Alzheimer's is a degenerative brain disease involving the parts of the brain that control thought, memory, and language. Progression of Alzheimer's leads to mental deterioration, disorientation, memory disturbance, and confusion.

assay

 A laboratory test to detect and/or measure the amount or activity of a specific substance.

assay validation

The evaluation of a test method (assay) to determine its fitness for a particular use.

autoimmune disease

Diseases in which the body's immune system attacks certain parts of the body "thinking" its own cells are foreign. Examples include multiple sclerosis, psoriasis, lupus. People with ALS are prone to developing autoimmune diseases.

Footer

Target ALS
  • Donate
  • Contact
  • Financial Reports
  • Call For Proposals
  • Annual Meeting
  • Privacy Policy
  • Credits

Follow Us

We are a 501(c)(3) public charity (EIN: 81-0756743), eligible to receive tax-deductible contributions that directly support our mission to break down barriers to ALS research to find effective treatments.

The Target ALS (TALS) website is intended for informational purposes only. Opinions expressed may not be that of TALS or its employees. For more information about our digital policies, click here.

© 2023 Target ALS Foundation, Inc.
Target ALS Foundation
244 Madison Avenue #1025
New York, NY 10016
(332) 333-4140
Steck Insights WordPress Consulting

Get our Summer Impact Report in your inbox – a special recap of our Annual Meeting and the progress we're making in ALS research.

Name(Required)
Interests(Required)
Mark the options that best describe your interest in ALS